On May 11th, Dingtai Pharmaceutical (839587) shareholder Tongxiang Laiyisheng Investment Management Partnership (Limited Partnership) increased its holdings by 1.029 million shares in the stock transfer system through call auction transfer on May 10, 2018, and the number of shares increased 4.12%, the current shareholding ratio is 24%.

It is understood that on May 10, 2018, Dingtai Pharmaceutical's shareholder Tongxiang Laiyisheng Investment Management Partnership (Limited Partnership) completed an increase in holdings of 1.029 million shares in the national SME share transfer system through call auction transfer. Before the equity change, Tongxiang Laiyisheng Investment Management Partnership (Limited Partnership) held 18.88% of the shares, and after the equity change, the shareholding ratio was 24%.

It is understood that the transfer is a result of Tongxiang Laiyisheng Investment Management Partnership (Limited Partnership) through the National Small and Medium-sized Enterprise Share Transfer System by means of collective bidding to increase its holdings of Dingtai Pharmaceutical’s unrestricted circulation shares. There is no equity transfer agreement, Administrative transfer or change, court ruling situation.